Key points are not available for this paper at this time.
A BSTRACT Introduction: Patients with significant maxillary atrophy who are not candidates for standard implants now have an option thanks to zygomatic implants. Long-term statistics on difficulties and success are, however, scarce. Methods: A tertiary care center’s patient data were retrospectively analyzed. Included were patients who underwent zygomatic implant surgery between 2017 and 2022. This research gathered and examined data on follow-up, surgical techniques, complications, demographics, and implant features. Findings: There were 100 patients in all. 92% of the implants were successful, and 92 of them survived. Peri-implantitis (20%), soft tissue dehiscence (15%), sinusitis (10%), prosthesis fracture (8%), and infection (5%), were among the biological consequences. In summary, zygomatic implants have the potential to help individuals with severe maxillary atrophy recover, but close observation and effective management of any problems are necessary to maximize results. To enhance patient care and improve treatment regimens, further research is required.
Dash et al. (Fri,) studied this question.